How do new therapeutic strategies for PCOS management influence the health of the affected individuals? The narrative review

Wójcik, Aleksandra, Wojtas, Jan, Margas, Mikołaj, Warchoł, Konrad, Stępniak, Karol. How do new therapeutic strategies for PCOS management influence the health of the affected individuals? The narrative review. Journal of Education, Health and Sport. 2022;12(10):294-300. eISSN 2391-8306. DOI http://dx.doi.org/10.12775/JEHS.2022.12.10.035

https://apcz.umk.pl/JEHS/article/view/40009

https://zenodo.org/record/7274805

The journal has had 40 points in Ministry of Education and Science of Poland parametric evaluation. Annex to the announcement of the Minister of Education and Science of December 21, 2021. No. 32343.

Has a Journal's Unique Identifier: 201159. Scientific disciplines assigned: Physical Culture Sciences (Field of Medical sciences and health sciences); Health Sciences (Field of Medical Sciences and Health Sciences).

Punkty Ministerialne z 2019 - aktualny rok 40 punktów. Załącznik do komunikatu Ministra Edukacji i Nauki z dnia 21 grudnia 2021 r. Lp. 32343. Posiada Unikatowy Identyfikator Czasopisma: 201159.

Przypisane dyscypliny naukowe: Nauki o kulturze fizycznej (Dziedzina nauk medycznych i nauk o zdrowiu); Nauki o zdrowiu (Dziedzina nauk medycznych i nauk o zdrowiu).

© The Authors 2022;

This article is published with open access at Licensee Open Journal Systems of Nicolaus Copernicus University in Torun, Poland

Open Access. This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author (s) and source are credited. This is an open access article licensed under the terms of the Creative Commons Attribution Non commercial license Share alike.

(http://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non commercial use, distribution and reproduction in any medium, provided the work is properly cited.

The authors declare that there is no conflict of interests regarding the publication of this paper.

Received: 14.09.2022. Revised: 20.10.2022. Accepted: 31.10.2022.

How do new therapeutic strategies for PCOS management influence the health of the affected individuals? The narrative review

Aleksandra Wójcik (1); https://orcid.org/0000-0003-1669-7466; awojcik115@gmail.com

Jan Wojtas (1); https://orcid.org/0000-0003-1393-3689; jan.wojtas7@gmail.com 

Mikołaj Margas (1); https://orcid.org/0000-0002-7420-0190; mikolajmargas@interia.pl

Konrad Warchoł (1); https://orcid.org/0000-0001-9467-680X; konrad.wrh@gmail.com

Karol Stępniak (1); https://orcid.org/0000-0002-8134-7967; karol.stepniak3@gmail.com 

1 – Medical University of Lublin

Abstract

Introduction and purpose: Management of polycystic ovary syndrome (PCOS) is difficult since the exact pathogenic mechanism has not been established yet. Due to that fact, the substances registered to treat PCOS are still lacking efficacy and are associated with a number of adverse effects. The aim of this study is to review new possible treatment approaches.

State of knowledge: Inositol administered alone or combined with oral contraceptive drugs improves patients’ hormonal status and alleviates the weight increase in comparison to oral contraceptive drugs on their own. Berberine reduces insulin resistance, improves lipid metabolism, and reduces inflammatory reactions. Glucagon-like peptide-1 receptor agonists have a better weight loss effect and less severe adverse reactions than metformin. Thiazolidinediones combined with metformin improve ovulation rate, acne and increase SHGB levels. Thiazolidinediones have also less severe adverse reactions than metformin and can be useful in patients who are not able to tolerate metformin.

Summary: The review has shown that inositol, berberine, glucagon-like peptide-1 receptor agonists and thiazolidinediones have promising therapeutic effects in terms of PCOS treatment, however, more research is needed to establish safety and efficacy of those agents. Nonetheless, results of this study may be utilized in the education of health specialists in endocrinology departments.

Keywords: “polycystic ovary syndrome”; “gonadal disorders”; inositol; berberine; “glucagon-like peptide-1”; thiazolidinediones